Research
An mRNA booster for cellular immunotherapy shows potential against aggressive brain tumors
The Brief
- A team led by the German Cancer Research Center (DKFZ) and University Medical Center Mannheim (UMM) developed a new approach to direct immune cells more effectively against glioblastomas.
- In experimental models, the researchers showed that a targeted mRNA booster can strengthen this cellular immunotherapy approach.
Why it matters
Glioblastomas are aggressive brain tumours with limited treatment options, so a way to improve immune cell therapy is relevant to cancer researchers, though the results so far come from experimental models rather than patients.
Who’s affected
- patients with glioblastoma and their clinicians
- cancer immunotherapy and mRNA researchers
- #glioblastoma
- #mrna
- #cancer immunotherapy
- #brain tumours
- #cell therapy
A team led by researchers at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) has developed a new approach to more effectively direct immune cells against glioblastomas. In experimental models, they were able to show that a targeted mRNA…